Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

Silva: Bad Data is Root of Problem with CT and MRI Cost Centers

Acknowledging and fixing the flawed capital cost data that CMS is using to justify proposed cuts in CT and MRI reimbursement is the responsibility of all radiology professionals writes Ezequiel Silva III, MD, in the latest issue of Radiology Business Journal

FDA clears Siemens’ Symbia Intevo integrated SPECT and CT system

Siemens Healthcare has announced that the FDA has granted 510(k) clearance for Symbia Intevo—the world’s first xSPECT system, which combines the high sensitivity of single-photon emission computed tomography (SPECT) with the high specificity of CT.

Metabolic PET imaging provides clues to developing Huntington’s disease

A functional neural network is under investigation as a major player in the progression of Huntington’s disease. Metabolic imaging of this region could serve as a tool for future treatments, according to a study published online Aug. 29 in the Journal of Clinical Investigation.

Chasing the lightning: Molecular epilepsy imaging with PET and SPECT

Recent studies have indicated that epilepsy may be more comprehensively characterized with the help of PET and SPECT, and these modalities could benefit the 1-2 percent of the U.S. population with the neurological disorder, according to a review published online Aug 22 in the Journal of Nuclear Medicine.

Thumbnail

Estrogen receptor PET imaging detects early stage breast cancer, with limitations

Early-stage breast cancer lesions can be detected with F-18 FES PET, but success depends on tumor size and level of disease, according to a study published online Aug. 22 in the Journal of Nuclear Medicine.

Radical Radiopharmaceuticals: Molecular Imaging Agents Find Their Niche

Multiple radiopharmaceuticals in the development pipeline are showing real promise in the realms of oncology, neurology and cardiology.

PET on a Leash: Reimbursement Developments and Challenges

The operative phrase for PET reimbursement circa 2013 may be “cautiously optimistic.”

Radiation Exposure: Connecting the Dots

The right dose to the right patient at the right time is the mantra. But tracking dose is gaining in popularity among physicians and patients.